{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:06:49Z","timestamp":1778868409966,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obsessive\u2013compulsive disorder (OCD) is a mental condition that affects many people and is characterized by recurring obsessions and compulsions. It significantly impacts individuals\u2019 ability to function ordinarily daily, affecting people of all ages. This study aimed to investigate whether or not the cytokines granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin-17 (IL-17) are involved in the pathophysiology of OCD. A case\u2013control study with 50 OCD patients and 38 healthy volunteers served as the controls for this investigation. The levels of GM-CSF and IL-17 in the serum of both groups were measured with enzyme-linked immunosorbent assay (ELISA) kits. In addition, the sociodemographic characteristics of the population under study were studied. Based on the findings of this study, OCD patients had significantly elevated levels of IL-17 than the controls, it appears that there may be a function for IL-17 in the pathophysiology of OCD. It was also discovered that the severity of OCD and IL-17 levels had a significant positive correlation. On the other hand, when comparing the levels of GM-CSF, there was no significant difference between the patients and the controls. This study provides evidence supporting the involvement of cytokine IL-17 in the pathophysiology of OCD. This study suggests IL-17 as a diagnostic biomarker for OCD and adds to our knowledge of the function that the immune system plays in this condition.<\/jats:p>","DOI":"10.1038\/s41598-023-46401-8","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T11:01:46Z","timestamp":1699009306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of granulocyte macrophage colony-stimulating factor and interleukin-17 levels with obsessive\u2013compulsive disorder: a case\u2013control study findings"],"prefix":"10.1038","volume":"13","author":[{"given":"Rapty","family":"Sarker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M. A. Shalahuddin","family":"Qusar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sardar Mohammad Ashraful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohiuddin Ahmed","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2820-3144","authenticated-orcid":false,"given":"Md. Rabiul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"issue":"3","key":"46401_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.psc.2014.06.004","volume":"37","author":"WK Goodman","year":"2014","unstructured":"Goodman, W. K. et al. Obsessive-compulsive disorder. Psychiatr. Clin. N. Am. 37(3), 257\u2013267. https:\/\/doi.org\/10.1016\/j.psc.2014.06.004 (2014).","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"3","key":"46401_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1212\/01.CON.0000466666.12779.07","volume":"21","author":"DA Drubach","year":"2015","unstructured":"Drubach, D. A. Obsessive-compulsive disorder. Continuum 21(3), 783\u2013788. https:\/\/doi.org\/10.1212\/01.CON.0000466666.12779.07 (2015).","journal-title":"Continuum"},{"key":"46401_CR3","doi-asserted-by":"publisher","first-page":"g2183","DOI":"10.1136\/bmj.g2183","volume":"348","author":"D Veale","year":"2014","unstructured":"Veale, D. & Roberts, A. Obsessive-compulsive disorder. BMJ 348, g2183. https:\/\/doi.org\/10.1136\/bmj.g2183 (2014).","journal-title":"BMJ"},{"issue":"2","key":"46401_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.31887\/DCNS.2010.12.2\/dmurphy","volume":"12","author":"DL Murphy","year":"2010","unstructured":"Murphy, D. L. et al. Obsessive-compulsive disorder and its related disorders: A reappraisal of obsessive-compulsive spectrum concepts. Dial. Clin. Neurosci. 12(2), 131\u2013148. https:\/\/doi.org\/10.31887\/DCNS.2010.12.2\/dmurphy (2010).","journal-title":"Dial. Clin. Neurosci."},{"issue":"1","key":"46401_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mp.2008.94","volume":"15","author":"AM Ruscio","year":"2010","unstructured":"Ruscio, A. M. et al. The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication. Mol. Psychiatry 15(1), 53\u201363. https:\/\/doi.org\/10.1038\/mp.2008.94 (2010).","journal-title":"Mol. Psychiatry"},{"issue":"Suppl 12","key":"46401_CR6","first-page":"7","volume":"58","author":"Y Sasson","year":"1997","unstructured":"Sasson, Y. et al. Epidemiology of obsessive-compulsive disorder: A world view. J. Clin. Psychiatry 58(Suppl 12), 7\u201310 (1997).","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"46401_CR7","first-page":"102","volume":"8","author":"RL DuPont","year":"1995","unstructured":"DuPont, R. L. et al. Economic costs of obsessive-compulsive disorder. Med. Interface 8(4), 102\u2013109 (1995).","journal-title":"Med. Interface"},{"issue":"1","key":"46401_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuron.2019.01.046","volume":"102","author":"TW Robbins","year":"2019","unstructured":"Robbins, T. W., Vaghi, M. M. & Banca, P. Obsessive-compulsive disorder: Puzzles and prospects. Neuron 102(1), 27\u201347. https:\/\/doi.org\/10.1016\/j.neuron.2019.01.046 (2019).","journal-title":"Neuron"},{"issue":"3","key":"46401_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.psc.2014.05.006","volume":"37","author":"C Pittenger","year":"2014","unstructured":"Pittenger, C. & Bloch, M. H. Pharmacological treatment of obsessive-compulsive disorder. Psychiatr. Clin. N. Am. 37(3), 375\u2013391. https:\/\/doi.org\/10.1016\/j.psc.2014.05.006 (2014).","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"1","key":"46401_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","volume":"5","author":"DJ Stein","year":"2019","unstructured":"Stein, D. J. et al. Obsessive-compulsive disorder. Nat. Rev. Dis. Primers 5(1), 52. https:\/\/doi.org\/10.1038\/s41572-019-0102-3 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"13","key":"46401_CR11","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1017\/S0033291721001744","volume":"51","author":"B Mahjani","year":"2021","unstructured":"Mahjani, B. et al. Genetics of obsessive-compulsive disorder. Psychol. Med. 51(13), 2247\u20132259. https:\/\/doi.org\/10.1017\/S0033291721001744 (2021).","journal-title":"Psychol. Med."},{"key":"46401_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jad.2020.11.037","volume":"281","author":"T Xu","year":"2021","unstructured":"Xu, T. et al. Impaired cortico-striatal functional connectivity is related to trait impulsivity in unmedicated patients with obsessive-compulsive disorder. J. Affect. Disord. 281, 899\u2013907. https:\/\/doi.org\/10.1016\/j.jad.2020.11.037 (2021).","journal-title":"J. Affect. Disord."},{"key":"46401_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbr.2016.07.004","volume":"313","author":"W Tang","year":"2016","unstructured":"Tang, W. et al. Cortico-striato-thalamo-cortical circuit abnormalities in obsessive-compulsive disorder: A voxel-based morphometric and fmri study of the whole brain. Behav. Brain Res. 313, 17\u201322. https:\/\/doi.org\/10.1016\/j.bbr.2016.07.004 (2016).","journal-title":"Behav. Brain Res."},{"issue":"2","key":"46401_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/24750573.2019.1583481","volume":"29","author":"B Dogan","year":"2019","unstructured":"Dogan, B. et al. Cortico-thalamo-striatal circuit components\u2019 volumes and their correlations differ significantly among patients with obsessive\u2013compulsive disorder: A case\u2013control MRI study. Psychiatry Clin. Psychopharmacol. 29(2), 162\u2013170. https:\/\/doi.org\/10.1080\/24750573.2019.1583481 (2019).","journal-title":"Psychiatry Clin. Psychopharmacol."},{"issue":"1","key":"46401_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.psc.2009.11.001","volume":"33","author":"G Nestadt","year":"2010","unstructured":"Nestadt, G., Grados, M. & Samuels, J. F. Genetics of obsessive-compulsive disorder. Psychiatr. Clin. N. Am. 33(1), 141\u2013158. https:\/\/doi.org\/10.1016\/j.psc.2009.11.001 (2010).","journal-title":"Psychiatr. Clin. N. Am."},{"key":"46401_CR16","doi-asserted-by":"publisher","first-page":"561266","DOI":"10.3389\/fpsyt.2020.561266","volume":"11","author":"K Murayama","year":"2020","unstructured":"Murayama, K. et al. Impacts of stressful life events and traumatic experiences on onset of obsessive-compulsive disorder. Front. Psychiatry 11, 561266. https:\/\/doi.org\/10.3389\/fpsyt.2020.561266 (2020).","journal-title":"Front. Psychiatry"},{"issue":"3","key":"46401_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11920-012-0272-0","volume":"14","author":"SM Gray","year":"2012","unstructured":"Gray, S. M. & Bloch, M. H. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr. Psychiatry Rep. 14(3), 220\u2013228. https:\/\/doi.org\/10.1007\/s11920-012-0272-0 (2012).","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"46401_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5214\/ans.0972.7531.180410","volume":"19","author":"S ThyagaRajan","year":"2012","unstructured":"ThyagaRajan, S. & Priyanka, H. P. Bidirectional communication between the neuroendocrine system and the immune system: Relevance to health and diseases. Ann. Neurosci. 19(1), 40\u201346. https:\/\/doi.org\/10.5214\/ans.0972.7531.180410 (2012).","journal-title":"Ann. Neurosci."},{"key":"46401_CR19","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.3389\/fimmu.2021.703527","volume":"12","author":"A Ferro","year":"2021","unstructured":"Ferro, A., Auguste, Y. S. & Cheadle, L. Microglia, cytokines, and neural activity: Unexpected interactions in brain development and function. Front. Immunol. 12, 3527. https:\/\/doi.org\/10.3389\/fimmu.2021.703527 (2021).","journal-title":"Front. Immunol."},{"key":"46401_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fpsyt.2019.00030","volume":"10","author":"H Himmerich","year":"2019","unstructured":"Himmerich, H. et al. Cytokine research in depression: Principles, challenges, and open questions. Front. Psychiatry 10, 30. https:\/\/doi.org\/10.3389\/fpsyt.2019.00030 (2019).","journal-title":"Front. Psychiatry"},{"key":"46401_CR21","doi-asserted-by":"publisher","first-page":"110740","DOI":"10.1016\/j.pnpbp.2023.110740","volume":"125","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Peripheral cytokine levels across psychiatric disorders: A systematic review and network meta-analysis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 125, 110740. https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110740 (2023).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"46401_CR22","doi-asserted-by":"publisher","first-page":"e0276619","DOI":"10.1371\/journal.pone.0276619","volume":"17","author":"S Islam","year":"2022","unstructured":"Islam, S. et al. Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study. PLoS ONE 17(11), e0276619. https:\/\/doi.org\/10.1371\/journal.pone.0276619 (2022).","journal-title":"PLoS ONE"},{"issue":"4","key":"46401_CR23","doi-asserted-by":"publisher","first-page":"e1175","DOI":"10.1002\/hsr2.1175","volume":"6","author":"Z Nahar","year":"2023","unstructured":"Nahar, Z. et al. Evaluation of serum interleukin-1 receptor antagonist levels in major depressive disorder: A case-control study. Health Sci. Rep. 6(4), e1175. https:\/\/doi.org\/10.1002\/hsr2.1175 (2023).","journal-title":"Health Sci. Rep."},{"issue":"1","key":"46401_CR24","doi-asserted-by":"publisher","first-page":"e3868","DOI":"10.7759\/cureus.3868","volume":"11","author":"NL Nishuty","year":"2019","unstructured":"Nishuty, N. L. et al. Evaluation of serum interleukin-6 and C-reactive protein levels in drug-na\u00efve major depressive disorder patients. Cureus 11(1), e3868. https:\/\/doi.org\/10.7759\/cureus.3868 (2019).","journal-title":"Cureus"},{"key":"46401_CR25","doi-asserted-by":"publisher","first-page":"113568","DOI":"10.1016\/j.psychres.2020.113568","volume":"295","author":"R Das","year":"2021","unstructured":"Das, R. et al. Higher levels of serum IL-1\u03b2 and TNF-\u03b1 are associated with an increased probability of major depressive disorder. Psychiatry Res. 295, 113568. https:\/\/doi.org\/10.1016\/j.psychres.2020.113568 (2021).","journal-title":"Psychiatry Res."},{"key":"46401_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","volume":"246","author":"JC Felger","year":"2013","unstructured":"Felger, J. C. & Lotrich, F. E. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience. 246, 199\u2013229. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.04.060 (2013).","journal-title":"Neuroscience."},{"issue":"2","key":"46401_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cyto.2015.05.030","volume":"75","author":"P Bhattacharya","year":"2015","unstructured":"Bhattacharya, P. et al. GM-CSF: An immune modulatory cytokine that can suppress autoimmunity. Cytokine 75(2), 261\u2013271. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.030 (2015).","journal-title":"Cytokine"},{"issue":"1","key":"46401_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-017-1042-z","volume":"14","author":"N Rodr\u00edguez","year":"2017","unstructured":"Rodr\u00edguez, N. et al. Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. J. Neuroinflamm. 14(1), 261 (2017).","journal-title":"J. Neuroinflamm."},{"key":"46401_CR29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14791","author":"AM Alsheikh","year":"2021","unstructured":"Alsheikh, A. M. & Alsheikh, M. M. Obsessive-compulsive disorder with rheumatological and inflammatory diseases: A systematic review. Cureus. https:\/\/doi.org\/10.7759\/cureus.14791 (2021).","journal-title":"Cureus."},{"issue":"2","key":"46401_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.30773\/pi.2019.0206","volume":"17","author":"J Park","year":"2020","unstructured":"Park, J. et al. Functional connectivity of the striatum as a neural correlate of symptom severity in patient with obsessive-compulsive disorder. Psychiatry Investig. 17(2), 87\u201395. https:\/\/doi.org\/10.30773\/pi.2019.0206 (2020).","journal-title":"Psychiatry Investig."},{"issue":"1","key":"46401_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12974-020-01903-4","volume":"17","author":"HO Dikmen","year":"2020","unstructured":"Dikmen, H. O. et al. GM-CSF induces noninflammatory proliferation of microglia and disturbs electrical neuronal network rhythms in situ. J. Neuroinflamm. 17(1), 4. https:\/\/doi.org\/10.1186\/s12974-020-01903-4 (2020).","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"46401_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-065x.2008.00699.x","volume":"226","author":"Y Iwakura","year":"2008","unstructured":"Iwakura, Y. et al. The roles of IL-17 in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226(1), 57\u201379. https:\/\/doi.org\/10.1111\/j.1600-065x.2008.00699.x (2008).","journal-title":"Immunol. Rev."},{"issue":"11","key":"46401_CR33","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.4049\/jimmunol.1801042","volume":"201","author":"PS Biswas","year":"2018","unstructured":"Biswas, P. S. IL-17 in renal immunity and autoimmunity. J. Immunol. 201(11), 3153\u20133159. https:\/\/doi.org\/10.4049\/jimmunol.1801042 (2018).","journal-title":"J. Immunol."},{"key":"46401_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2014.03.004","volume":"41","author":"DM Moynes","year":"2014","unstructured":"Moynes, D. M., Vanner, S. J. & Lomax, A. E. Participation of interleukin 17A in neuroimmune interactions. Brain Behav. Immun. 41, 1\u20139. https:\/\/doi.org\/10.1016\/j.bbi.2014.03.004 (2014).","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"46401_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/joim.13282","volume":"290","author":"CRH Hedin","year":"2021","unstructured":"Hedin, C. R. H. et al. Inflammatory bowel disease and psoriasis: Modernizing the multidisciplinary approach. J. Intern. Med. 290(2), 257\u2013278. https:\/\/doi.org\/10.1111\/joim.13282 (2021).","journal-title":"J. Intern. Med."},{"key":"46401_CR36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fmed.2018.00364","volume":"5","author":"M Robert","year":"2019","unstructured":"Robert, M. & Miossec, P. IL-17 in rheumatoid arthritis and precision medicine: From synovitis expression to circulating bioactive levels. Front. Med. 5, 364. https:\/\/doi.org\/10.3389\/fmed.2018.00364 (2019).","journal-title":"Front. Med."},{"issue":"8","key":"46401_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/ijnp\/pyw027","volume":"19","author":"S \u015eim\u015fek","year":"2016","unstructured":"\u015eim\u015fek, S. et al. Serum cytokine profiles of children with obsessive-compulsive disorder shows the evidence of autoimmunity. Int. J. Neuropsychopharmacol. 19(8), 27 (2016).","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"11","key":"46401_CR38","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/diagnostics10110926","volume":"10","author":"MM Borovcanin","year":"2020","unstructured":"Borovcanin, M. M. et al. Type 17 immune response facilitates progression of inflammation and correlates with cognition in stable schizophrenia. Diagnostics 10(11), 926. https:\/\/doi.org\/10.3390\/diagnostics10110926 (2020).","journal-title":"Diagnostics"},{"issue":"1","key":"46401_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-01013-y","volume":"10","author":"WB Bruin","year":"2020","unstructured":"Bruin, W. B. et al. Structural neuroimaging biomarkers for obsessive-compulsive disorder in the Enigma-OCD consortium: Medication matters. Transl. Psychiatry 10(1), 1. https:\/\/doi.org\/10.1038\/s41398-020-01013-y (2020).","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"46401_CR40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/wps.21078","volume":"22","author":"A Abi-Dargham","year":"2023","unstructured":"Abi-Dargham, A. et al. Candidate biomarkers in psychiatric disorders: State of the field. World Psychiatry. 22(2), 236\u2013262. https:\/\/doi.org\/10.1002\/wps.21078 (2023).","journal-title":"World Psychiatry."},{"key":"46401_CR41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fpsyt.2020.00432","volume":"11","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2020","unstructured":"Garc\u00eda-Guti\u00e9rrez, M. S. et al. Biomarkers in psychiatry: Concept, definition, types and relevance to the clinical reality. Front. Psychiatry 11, 432. https:\/\/doi.org\/10.3389\/fpsyt.2020.00432 (2020).","journal-title":"Front. Psychiatry"},{"issue":"11","key":"46401_CR42","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman, W. K. et al. The Yale-brown obsessive compulsive scale. II. Validity. Arch. Gen. Psychiatry 46(11), 1012\u20131016. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810110054008 (1989).","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"46401_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4137\/JCNSD.S38359","volume":"2016","author":"AM Rapp","year":"2021","unstructured":"Rapp, A. M., Bergman, R. L., Piacentini, J. & McGuire, J. F. Evidence-based assessment of obsessive-compulsive disorder. J. Cent. Nerv. Syst. Dis. 2016(8), 13\u201329. https:\/\/doi.org\/10.4137\/JCNSD.S38359 (2021).","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"46401_CR44","doi-asserted-by":"publisher","first-page":"76710","DOI":"10.2147\/ijicmr.s76710","volume":"35","author":"D Marazziti","year":"2015","unstructured":"Marazziti, D. et al. The cytokine profile of OCD: Pathophysiological insights. Int. J. Interferon Cytokine Mediat. Res. 35, 76710. https:\/\/doi.org\/10.2147\/ijicmr.s76710 (2015).","journal-title":"Int. J. Interferon Cytokine Mediat. Res."},{"key":"46401_CR45","volume-title":"StatPearls","author":"A Bakshi","year":"2022","unstructured":"Bakshi, A. & Tadi, P. Biochemistry, serotonin. In StatPearls (eds Bakshi, A. & Tadi, P.) (StatPearls Publishing, 2022)."},{"issue":"9","key":"46401_CR46","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0269881117711708","volume":"31","author":"P Kopschina Feltes","year":"2017","unstructured":"Kopschina Feltes, P. et al. Anti-inflammatory treatment for major depressive disorder: Implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J. Psychopharmacol. 31(9), 1149\u20131165. https:\/\/doi.org\/10.1177\/0269881117711708 (2017).","journal-title":"J. Psychopharmacol."},{"key":"46401_CR47","doi-asserted-by":"publisher","first-page":"204512532091665","DOI":"10.1177\/2045125320916655","volume":"10","author":"S Anjum","year":"2020","unstructured":"Anjum, S. et al. Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder. Ther. Adv. Psychopharmacol. 10, 2045125320916655. https:\/\/doi.org\/10.1177\/2045125320916655 (2020).","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"Suppl 2","key":"46401_CR48","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato, D. J., Quan, N. & Godbout, J. P. Neuroinflammation: The devil is in the details. J. Neurochem. 139(Suppl 2), 136\u2013153. https:\/\/doi.org\/10.1111\/jnc.13607 (2016).","journal-title":"J. Neurochem."},{"key":"46401_CR49","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.3389\/fpsyt.2022.868921","volume":"13","author":"LC Sternheim","year":"2022","unstructured":"Sternheim, L. C. et al. Cognitive and experienced flexibility in patients with anorexia nervosa and obsessive compulsive disorder. Front. Psychiatry 13, 8921. https:\/\/doi.org\/10.3389\/fpsyt.2022.868921 (2022).","journal-title":"Front. Psychiatry"},{"issue":"10","key":"46401_CR50","first-page":"1353","volume":"165","author":"PD Arnold","year":"2001","unstructured":"Arnold, P. D. & Richter, M. A. Is obsessive-compulsive disorder an autoimmune disease? CMAJ 165(10), 1353\u20131358 (2001).","journal-title":"CMAJ"},{"issue":"1","key":"46401_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm, F. S. Receiver operating characteristic curve: Overview and practical use for clinicians. Korean J. Anesthesiol. 75(1), 25\u201336. https:\/\/doi.org\/10.4097\/kja.21209 (2022).","journal-title":"Korean J. Anesthesiol."},{"issue":"2","key":"46401_CR52","first-page":"627","volume":"4","author":"K Hajian-Tilaki","year":"2013","unstructured":"Hajian-Tilaki, K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J. Intern. Med. 4(2), 627\u2013635 (2013).","journal-title":"Caspian J. Intern. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46401-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46401-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46401-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T11:06:44Z","timestamp":1699009604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46401-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46401"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46401-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18976"}}